These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22591278)
1. Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study. Gianforcaro A; Hamadeh MJ CNS Neurosci Ther; 2012 Jul; 18(7):547-57. PubMed ID: 22591278 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females. Gianforcaro A; Solomon JA; Hamadeh MJ PLoS One; 2013; 8(2):e30243. PubMed ID: 23405058 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. Solomon JA; Gianforcaro A; Hamadeh MJ PLoS One; 2011; 6(12):e29354. PubMed ID: 22216257 [TBL] [Abstract][Full Text] [Related]
4. Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis. Moghimi E; Solomon JA; Gianforcaro A; Hamadeh MJ PLoS One; 2015; 10(5):e0126355. PubMed ID: 26020962 [TBL] [Abstract][Full Text] [Related]
5. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice. Hamadeh MJ; Tarnopolsky MA Muscle Nerve; 2006 Dec; 34(6):709-19. PubMed ID: 16941656 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Zhao Z; Fu J; Li S; Li Z J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663 [TBL] [Abstract][Full Text] [Related]
7. Protection by dietary zinc in ALS mutant G93A SOD transgenic mice. Ermilova IP; Ermilov VB; Levy M; Ho E; Pereira C; Beckman JS Neurosci Lett; 2005 Apr; 379(1):42-6. PubMed ID: 15814196 [TBL] [Abstract][Full Text] [Related]
8. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1 Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164 [TBL] [Abstract][Full Text] [Related]
9. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320 [TBL] [Abstract][Full Text] [Related]
10. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Hamadeh MJ; Rodriguez MC; Kaczor JJ; Tarnopolsky MA Muscle Nerve; 2005 Feb; 31(2):214-20. PubMed ID: 15625688 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394 [TBL] [Abstract][Full Text] [Related]
12. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962 [TBL] [Abstract][Full Text] [Related]
13. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Mahoney DJ; Rodriguez C; Devries M; Yasuda N; Tarnopolsky MA Muscle Nerve; 2004 May; 29(5):656-62. PubMed ID: 15116368 [TBL] [Abstract][Full Text] [Related]
14. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism. Cervetto C; Frattaroli D; Maura G; Marcoli M Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883 [TBL] [Abstract][Full Text] [Related]
15. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427 [TBL] [Abstract][Full Text] [Related]
16. Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS. Patel BP; Safdar A; Raha S; Tarnopolsky MA; Hamadeh MJ PLoS One; 2010 Feb; 5(2):e9386. PubMed ID: 20195368 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis. Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562 [TBL] [Abstract][Full Text] [Related]
18. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725 [TBL] [Abstract][Full Text] [Related]
19. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis. Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA Skelet Muscle; 2016; 6():24. PubMed ID: 27340545 [TBL] [Abstract][Full Text] [Related]
20. Galactooligosaccharide improves the animal survival and alleviates motor neuron death in SOD1G93A mouse model of amyotrophic lateral sclerosis. Song L; Gao Y; Zhang X; Le W Neuroscience; 2013 Aug; 246():281-90. PubMed ID: 23673277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]